A recent investigation discovered that the combination of recombinant mouse (rm) IL-18 with rmIL-23 exacerbates inflammation, upregulates IFN-γ and CXCL9, and enhances psoriasis-like epidermal hyperplasia [154]. This evidence concerns the gene IL18 and psoriasis.